These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6713791)

  • 21. Iohexol vs. iopamidol for myelography.
    Lamb JT
    Invest Radiol; 1985; 20(1 Suppl):S37-43. PubMed ID: 3882615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of platelet function by contrast media: iopamidol and ioxaglate versus iothalamate. Work in progress.
    Rao AK; Rao VM; Willis J; Beckett C; Steiner RM
    Radiology; 1985 Aug; 156(2):311-3. PubMed ID: 4011893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacochemical profile of iopromide.
    Muetzel W; Speck U
    AJNR Am J Neuroradiol; 1983; 4(3):350-2. PubMed ID: 6410742
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iohexol and metrizoate in urography in children. Comparison between a non-ionic and an ionic contrast medium.
    Bolz KD; Skalpe IO; Gutteberg TJ
    Acta Radiol Diagn (Stockh); 1984; 25(2):155-8. PubMed ID: 6731022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodixanol in intravenous urography: a comparison of iodixanol 270 mgI/ml, iodixanol 320 mgI/ml and iopamidol 300 mgI/ml (NIOPAM).
    Conroy RM; Bjartveit K; Sheppick A; Long U; Masterson J
    Clin Radiol; 1994 May; 49(5):337-40. PubMed ID: 8013200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advantages of nonionic contrast agents in adult urography.
    Dray RJ; Winfield AC; Muhletaler CA; Kirchner FK
    Urology; 1984 Sep; 24(3):297-9. PubMed ID: 6382739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urography with a low osmolality contrast agent. Comparison of Hexabrix with Conray 325.
    McClennan BL; Ling D; Rholl KS; James M
    Invest Radiol; 1986 Feb; 21(2):144-50. PubMed ID: 3957588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemotoxicity of contrast media and clinical adverse effects: a review.
    Dawson P
    Invest Radiol; 1985; 20(1 Suppl):S84-91. PubMed ID: 2579046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of low osmolality water soluble (LOWS) contrast media in the pediatric gastro-intestinal tract. A report of 115 examinations.
    Ratcliffe JF
    Pediatr Radiol; 1986; 16(1):47-52. PubMed ID: 3945499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysis.
    Sovak M; Ranganathan R; Kerber CW; Bickford R; Alksne JF
    AJNR Am J Neuroradiol; 1983; 4(3):319-22. PubMed ID: 6410733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Adverse reactions following high-dose intravenous injection of urographic contrast media].
    Lackner K; Köster O; von Uexküll V; Broich H
    Rofo; 1984 Oct; 141(4):447-52. PubMed ID: 6436920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma osmolality, iodine concentration and urographic images following high and low osmolar contrast media.
    Todd AW; Naisby GP; Owen JP; Smith PA; Butler TJ; Kelly PJ; Murthy LN; Robson JY; Laker MF
    Clin Radiol; 1991 May; 43(5):331-6. PubMed ID: 2036759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low dose low osmolar intravenous urography.
    Eyes BE; Goldman M; Nixon TE; Scally J; Brown A
    Clin Radiol; 1987 Jul; 38(4):403-5. PubMed ID: 3304790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iopamidol in urography. A comparison between ionic and nonionic contrast media in patients with normal and impaired renal function.
    Dalla Palma L; Rossi M; Stacul F; Agostini R
    Urol Radiol; 1982; 4(1):1-3. PubMed ID: 7101596
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New contrast agents. Chemistry and pharmacology.
    Dawson P
    Invest Radiol; 1984; 19(6 Suppl):S293-300. PubMed ID: 6511274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iohexol compared with metrizoate in urography.
    Levorstad K; Kolbenstvedt A; Løyning EW
    Acta Radiol Diagn (Stockh); 1983; 24(4):337-42. PubMed ID: 6637574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experiences with rayvist and iopromid in head and body CT.
    Zeitler E; Böhnlein K; Gailer H; Lindner R; Richter EI
    Fortschr Geb Rontgenstrahlen Nuklearmed Erganzungsbd; 1983; 118():162-72. PubMed ID: 6139073
    [No Abstract]   [Full Text] [Related]  

  • 38. Safer, more expensive iodinated contrast agents: how do we decide?
    Wolf GL
    Radiology; 1986 May; 159(2):557-8. PubMed ID: 3961192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Low osmolality contrast media in peripheral arteriography--clinical comparison of ioxaglate, iopamidol, iohexol and diatrizoate].
    Tajima H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Nov; 45(11):1407-20. PubMed ID: 4094879
    [No Abstract]   [Full Text] [Related]  

  • 40. Contrast agents used for excretory urography impair platelet function in human patients.
    Belleville J; Freyria AM; Pinet A; Cornillon B; Paul J; Clendinnen G; Eloy R
    Thromb Res; 1982 Nov; 28(4):533-44. PubMed ID: 7164034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.